Pioneer work by Prof. Cossart among others, studying the interactions between pathogenic bacteria and host cells (this discipline was termed Cellular Microbiology), was fundamental to determine the bacterial infection processes and to improve our knowledge of different cellular mechanisms.
The study of bacteria-host interactions also involves in vivo host immune responses, which can be manipulated by bacteria, being these last potent tools for different immunotherapies.
During the last years, tumour immunotherapies, mainly the use of antibodies that target immune checkpoints [checkpoint inhibitors (CPI)], have been a revolution in oncology, allowing the treatment of tumours otherwise with very bad prognosis. In the same direction, bacteria inoculations have been used from long to treat some cancers; for example, non-muscle-invasive bladder cancer can be successfully treated with the bacterium Bacillus Calmette Guerin (BCG).
AKR/12B-2 |
|||
ABC-TC205S | AcceGen | 1 vial | Ask for price |
Description: Tissue: thymus; Transformed by: X-rays. The cells express Lyt-2, Lyt-3 and CD4 in the cytosol, but not on the membrane; They reexpress Lyt-2, Lyt-3 and CD4 on the membrane after sorting by magnetic particles (5 cycles). |
AKR/12B-3 |
|||
ABC-TC206S | AcceGen | 1 vial | Ask for price |
Description: Tissue: thymus; Transformed by: X-rays. The cells express Lyt-2, Lyt-3 and CD4 in the cytosol, but not on the membrane; They do not reexpress Lyt-2, Lyt-3 and CD4 on the membrane after sorting by magnetic particles (5 cycles). |
Ala-Lys-Arg (AKR) |
|||
070-06 | PHOENIX PEPTIDE | 5 mg | EUR 102.6 |
AT-130 |
|||
530587 | MedKoo Biosciences | 5.0mg | EUR 350 |
AH-130 |
|||
ABC-TC0040 | AcceGen | 1 vial | Ask for price |
Description: Established in vitro from the AH-130 tumor-ascites, RAP-Test negative The species was confirmed by Real-Time PCR. |
GIBH-130 |
|||
B2071-25 | Biovision | each | EUR 907.2 |
GIBH-130 |
|||
B2071-5 | Biovision | each | EUR 274.8 |
HA 130 |
|||
B7612-10 | ApexBio | 10 mg | EUR 186 |
Description: autotaxin inhibitor |
HA 130 |
|||
B7612-100 | ApexBio | 100mg | EUR 992 |
Description: autotaxin inhibitor |
HA 130 |
|||
B7612-25 | ApexBio | 25 mg | EUR 289.2 |
HA 130 |
|||
B7612-5 | ApexBio | 5 mg | EUR 133 |
Description: autotaxin inhibitor |
HA 130 |
|||
B7612-50 | ApexBio | 50mg | EUR 595 |
Description: autotaxin inhibitor |
HA 130 |
|||
B1192-25 | Biovision | each | EUR 496.8 |
GIBH-130 |
|||
555149 | MedKoo Biosciences | 10.0mg | EUR 150 |
MSX-130 |
|||
555221 | MedKoo Biosciences | 10.0mg | EUR 150 |
CAL-130 |
|||
HY-16122A | MedChemExpress | 5mg | EUR 424.8 |
GIBH-130 |
|||
HY-101860 | MedChemExpress | 10mM/1mL | EUR 256.8 |
MSX-130 |
|||
T4033-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: MSX-130 |
MSX-130 |
|||
T4033-1g | TargetMol Chemicals | 1g | Ask for price |
Description: MSX-130 |
MSX-130 |
|||
T4033-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: MSX-130 |
MSX-130 |
|||
T4033-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: MSX-130 |
MSX-130 |
|||
T4033-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: MSX-130 |
PK 130 |
|||
T34083-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: PK 130 |
PK 130 |
|||
T34083-1g | TargetMol Chemicals | 1g | Ask for price |
Description: PK 130 |
PK 130 |
|||
T34083-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: PK 130 |
PK 130 |
|||
T34083-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: PK 130 |
PK 130 |
|||
T34083-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: PK 130 |
CAL-130 |
|||
T10660-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: CAL-130 |
CAL-130 |
|||
T10660-1g | TargetMol Chemicals | 1g | Ask for price |
Description: CAL-130 |
CAL-130 |
|||
T10660-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: CAL-130 |
CAL-130 |
|||
T10660-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: CAL-130 |
CAL-130 |
|||
T10660-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: CAL-130 |
LP 130 |
|||
T24416-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: LP 130 |
LP 130 |
|||
T24416-1g | TargetMol Chemicals | 1g | Ask for price |
Description: LP 130 |
LP 130 |
|||
T24416-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: LP 130 |
LP 130 |
|||
T24416-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: LP 130 |
LP 130 |
|||
T24416-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: LP 130 |
G-130 |
|||
T27396-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: G-130 |
G-130 |
|||
T27396-1g | TargetMol Chemicals | 1g | Ask for price |
Description: G-130 |
G-130 |
|||
T27396-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: G-130 |
G-130 |
|||
T27396-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: G-130 |
G-130 |
|||
T27396-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: G-130 |
AT-130 |
|||
T26674-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: AT-130 |
AT-130 |
|||
T26674-1g | TargetMol Chemicals | 1g | Ask for price |
Description: AT-130 |
AT-130 |
|||
T26674-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: AT-130 |
AT-130 |
|||
T26674-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: AT-130 |
AT-130 |
|||
T26674-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: AT-130 |
GIBH-130 |
|||
T4450-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: GIBH-130 |
GIBH-130 |
|||
T4450-1g | TargetMol Chemicals | 1g | Ask for price |
Description: GIBH-130 |
GIBH-130 |
|||
T4450-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: GIBH-130 |
GIBH-130 |
|||
T4450-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: GIBH-130 |
GIBH-130 |
|||
T4450-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: GIBH-130 |
Lenti ORF particles, AKR1C3 (Myc-DDK tagged) - Human aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) (AKR |
|||
RC200210L1V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, AKR1C3 (Myc-DDK tagged) - Human aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) (AKR |
|||
RC200210L3V | Origene Technologies GmbH | 200 µl | Ask for price |
STF 210-130*130-B7527 AC Signs |
|||
222596 | BRADY NV | Card of 1 Pictogram(s) | EUR 6.54 |
Description: Description Dutch: Pictogram voor Brandbestrijding - ARRÊT D'URGENCE; Description French: Pictogramme sécurité incendie - Arrêt d’urgence |
STF 211-130*130-B7527 AC Signs |
|||
222598 | BRADY NV | Card of 1 Pictogram(s) | EUR 6.54 |
Description: Description Dutch: Pictogram voor Brandbestrijding - CLES CABINE; Description French: Pictogramme sécurité incendie - Clés cabine |
STF 212-130*130-B7527 AC Signs |
|||
222600 | BRADY NV | Card of 1 Pictogram(s) | EUR 6.54 |
Description: Description Dutch: Pictogram voor Brandbestrijding - COUPURE D'URGENCE; Description French: Pictogramme sécurité incendie - Coupure d’urgence |
STF 210-130*130-B7541 AC Signs |
|||
222832 | BRADY NV | Card of 1 Pictogram(s) | EUR 3.24 |
Description: Description Dutch: Pictogram voor Brandbestrijding - ARRÊT D'URGENCE; Description French: Pictogramme sécurité incendie - Arrêt d’urgence |
STF 211-130*130-B7541 AC Signs |
|||
222833 | BRADY NV | Card of 1 Pictogram(s) | EUR 3.24 |
Description: Description Dutch: Pictogram voor Brandbestrijding - CLES CABINE; Description French: Pictogramme sécurité incendie - Clés cabine |
STF 212-130*130-B7541 AC Signs |
|||
222834 | BRADY NV | Card of 1 Pictogram(s) | EUR 3.24 |
Description: Description Dutch: Pictogram voor Brandbestrijding - COUPURE D'URGENCE; Description French: Pictogramme sécurité incendie - Coupure d’urgence |
Musclin (105-130) / Osteocrin (Ostn) (105-130) (Mouse) |
|||
028-67 | PHOENIX PEPTIDE | 100 μg | EUR 214.92 |
Musclin (80-130) / Osteocrin (Ostn) (80-130) (Mouse) |
|||
028-69 | PHOENIX PEPTIDE | 100 μg | EUR 355.32 |
AH-130 FN |
|||
ABC-TC0041 | AcceGen | 1 vial | Ask for price |
Description: Established in vitro from the AH-130 FN tumor ascites (Cell Lines Service), RAP-Test negativ The species was confirmed by Real-Time PCR. |
IL16, (130 a.a.) |
|||
cyt-536 | ProSpec Tany | 2µg | EUR 60 |
Description: Recombinant Human Interleukin-16, (130 a.a.) |
CAL-130 Hydrochloride |
|||
A3268-10 | ApexBio | 10 mg | EUR 454 |
Description: PI3K inhibitor |
CAL-130 Hydrochloride |
|||
A3268-2 | ApexBio | 2mg | EUR 234 |
Description: PI3K inhibitor |
CAL-130 Hydrochloride |
|||
A3268-5 | ApexBio | 5 mg | EUR 352 |
Description: PI3K inhibitor |
CAL-130 Hydrochloride |
|||
A3268-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 584.4 |
Description: Class I phosphoinositide 3-kinase (PI3K) activate fundamental pathways controlling cell survival, metabolism, proliferation and and therefore play crucial role in cancer development. |
CAL-130 Hydrochloride |
|||
A3268-50 | ApexBio | 50 mg | EUR 1226 |
Description: PI3K inhibitor |
CAL-130 (Racemate) |
|||
HY-16122 | MedChemExpress | 50mg | EUR 1706.4 |
CAL-130 (Hydrochloride) |
|||
HY-16122B | MedChemExpress | 5mg | EUR 424.8 |
gp130/CD 130 |
|||
GT15072 | Neuromics | 100 ug | EUR 631.2 |
ZXH-4-130 |
|||
T40332-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: ZXH-4-130 |
ZXH-4-130 |
|||
T40332-1g | TargetMol Chemicals | 1g | Ask for price |
Description: ZXH-4-130 |
ZXH-4-130 |
|||
T40332-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: ZXH-4-130 |
ZXH-4-130 |
|||
T40332-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: ZXH-4-130 |
ZXH-4-130 |
|||
T40332-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: ZXH-4-130 |
CAL-130 Hydrochloride |
|||
T10660L-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: CAL-130 Hydrochloride |
CAL-130 Hydrochloride |
|||
T10660L-1g | TargetMol Chemicals | 1g | Ask for price |
Description: CAL-130 Hydrochloride |
CAL-130 Hydrochloride |
|||
T10660L-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: CAL-130 Hydrochloride |
CAL-130 Hydrochloride |
|||
T10660L-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: CAL-130 Hydrochloride |
CAL-130 Hydrochloride |
|||
T10660L-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: CAL-130 Hydrochloride |
CAL-130 Racemate |
|||
T10660L2-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: CAL-130 Racemate |
CAL-130 Racemate |
|||
T10660L2-1g | TargetMol Chemicals | 1g | Ask for price |
Description: CAL-130 Racemate |
CAL-130 Racemate |
|||
T10660L2-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: CAL-130 Racemate |
CAL-130 Racemate |
|||
T10660L2-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: CAL-130 Racemate |
CAL-130 Racemate |
|||
T10660L2-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: CAL-130 Racemate |
AC-4-130 |
|||
T35429-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: AC-4-130 |
AC-4-130 |
|||
T35429-1g | TargetMol Chemicals | 1g | Ask for price |
Description: AC-4-130 |
AC-4-130 |
|||
T35429-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: AC-4-130 |
AC-4-130 |
|||
T35429-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: AC-4-130 |
AC-4-130 |
|||
T35429-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: AC-4-130 |
Black box 130 x 130 x 50 mm - EACH |
|||
DD139735 | Scientific Laboratory Supplies | EACH | EUR 17.55 |
Musclin (105-130) / Osteocrin (Ostn) (105-130) (Mouse) - Biotin Labeled |
|||
B-028-67 | PHOENIX PEPTIDE | 20 μg | EUR 604.8 |
Musclin (80-130) / Osteocrin (Ostn) (80-130) (Mouse) - Biotin Labeled |
|||
B-028-69 | PHOENIX PEPTIDE | 10 μg | EUR 469.8 |
Musclin (80-130) / Osteocrin (Ostn) (80-130) (Mouse) - Cy3 Labeled |
|||
FC3-028-69 | PHOENIX PEPTIDE | 1 nmol | EUR 756 |
Musclin (80-130) / Osteocrin (Ostn) (80-130) (Mouse) - FAM Labeled |
|||
FG-028-69A | PHOENIX PEPTIDE | 1 nmol | EUR 469.8 |
Musclin (80-130) / Osteocrin (Ostn) (80-130) (Mouse) - Rhodamine Labeled |
|||
FR-028-69 | PHOENIX PEPTIDE | 1 nmol | EUR 469.8 |
Glycoprotein 130 (gp130) Antibody |
|||
20-abx101623 | Abbexa |
|
|
Glycoprotein 130 (gp130) Antibody |
|||
20-abx101624 | Abbexa |
|
|
Doc- 6 (130 - 145) |
|||
5-01045 | CHI Scientific | 4 x 1mg | Ask for price |
Dok-4 (130 - 145) |
|||
5-01046 | CHI Scientific | 4 x 1mg | Ask for price |
Leptin (116-130), mouse |
|||
5-01446 | CHI Scientific | 0.4 x 5mg | Ask for price |
Glycoprotein 130 (gp130) Antibody |
|||
20-abx129814 | Abbexa |
|
|
Glycoprotein 130 (gp130) Antibody |
|||
20-abx130860 | Abbexa |
|
|
LEP (116-130) (mouse) |
|||
A1024-1 | ApexBio | 1 mg | EUR 64 |
Description: An antiobesity hormone |
LEP (116-130) (mouse) |
|||
A1024-10 | ApexBio | 10 mg | EUR 320 |
Description: An antiobesity hormone |
LEP (116-130) (mouse) |
|||
A1024-25 | ApexBio | 25 mg | EUR 448 |
Description: An antiobesity hormone |
LEP (116-130) (mouse) |
|||
A1024-5 | ApexBio | 5 mg | EUR 192 |
Description: An antiobesity hormone |
Leptin (116-130) (human) |
|||
4107160.05 | Bachem | 0.5 mg | EUR 104.48 |
Leptin (116-130) (human) |
|||
4107160.1 | Bachem | 1 mg | EUR 177.56 |
Leptin (116-130) Peptide |
|||
20-abx265393 | Abbexa |
|
|
IL16 (130 a.a.) Protein |
|||
20-abx262202 | Abbexa |
|
|
Glycoprotein 130 (gp130) Antibody |
|||
20-abx172638 | Abbexa |
|
|
Glycoprotein 130 (gp130) Antibody |
|||
20-abx172639 | Abbexa |
|
|
Glycoprotein 130 (gp130) Antibody |
|||
20-abx176676 | Abbexa |
|
|
Hydroxyethyl starch 130 / 0.4 |
|||
20-abx186470 | Abbexa |
|
|
Active Glycoprotein 130 (gp130) |
|||
APA046Hu61 | Cloud-Clone | 10ug | EUR 320 |
LEP(116-130)(mouse) |
|||
HY-P1027 | MedChemExpress | 10mg | EUR 704.4 |
Leptin (116-130) (human) |
|||
H-8372.0500 | Bachem | 0.5mg | EUR 198 |
Description: Sum Formula: C70H106N18O24S |
Leptin (116-130) (human) |
|||
H-8372.1000 | Bachem | 1.0mg | EUR 312 |
Description: Sum Formula: C70H106N18O24S |
Eukaryotic Glycoprotein 130 (gp130) |
|||
EPA046Hu61 | Cloud-Clone | 10ug | EUR 280 |
Recombinant Glycoprotein 130 (gp130) |
|||
RPA046Hu01 | Cloud-Clone | 10ug | EUR 168 |
Recombinant Glycoprotein 130 (gp130) |
|||
4-RPA046Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Glycoprotein 130 expressed in: E.coli |
Recombinant Glycoprotein 130 (gp130) |
|||
RPA046Hu02 | Cloud-Clone | 10ug | EUR 168 |
Recombinant Glycoprotein 130 (gp130) |
|||
4-RPA046Hu02 | Cloud-Clone |
|
|
Description: Recombinant Human Glycoprotein 130 expressed in: E.coli |
Recombinant Glycoprotein 130 (gp130) |
|||
RPA046Mu01 | Cloud-Clone | 10ug | EUR 180 |
Recombinant Glycoprotein 130 (gp130) |
|||
4-RPA046Mu01 | Cloud-Clone |
|
|
Description: Recombinant Mouse Glycoprotein 130 expressed in: E.coli |
Recombinant Glycoprotein 130 (gp130) |
|||
RPA046Ra01 | Cloud-Clone | 10ug | EUR 180 |
Recombinant Glycoprotein 130 (gp130) |
|||
4-RPA046Ra01 | Cloud-Clone |
|
|
Description: Recombinant Rat Glycoprotein 130 expressed in: E.coli |
Recombinant Glycoprotein 130 (gp130) |
|||
RPU56383-100ug | Biomatik Corporation | 100ug | EUR 266.3 |
Recombinant Glycoprotein 130 (gp130) |
|||
RPU56383-1mg | Biomatik Corporation | 1mg | EUR 1235.6 |
Recombinant Glycoprotein 130 (gp130) |
|||
RPU56383-50ug | Biomatik Corporation | 50ug | EUR 190.1 |
Eukaryotic Glycoprotein 130 (gp130) |
|||
RPU59117-100ug | Biomatik Corporation | 100ug | EUR 1047.2 |
Eukaryotic Glycoprotein 130 (gp130) |
|||
RPU59117-1mg | Biomatik Corporation | 1mg | EUR 4095 |
Eukaryotic Glycoprotein 130 (gp130) |
|||
RPU59117-50ug | Biomatik Corporation | 50ug | EUR 654.5 |
Recombinant Glycoprotein 130 (gp130) |
|||
RPU53478-100ug | Biomatik Corporation | 100ug | EUR 554.4 |
Recombinant Glycoprotein 130 (gp130) |
|||
RPU53478-1mg | Biomatik Corporation | 1mg | EUR 2457 |
Recombinant Glycoprotein 130 (gp130) |
|||
RPU53478-50ug | Biomatik Corporation | 50ug | EUR 445.5 |
Recombinant Glycoprotein 130 (gp130) |
|||
RPU53479-100ug | Biomatik Corporation | 100ug | EUR 554.4 |
Recombinant Glycoprotein 130 (gp130) |
|||
RPU53479-1mg | Biomatik Corporation | 1mg | EUR 2457 |
Recombinant Glycoprotein 130 (gp130) |
|||
RPU53479-50ug | Biomatik Corporation | 50ug | EUR 445.5 |
Recombinant Glycoprotein 130 (gp130) |
|||
RPU41705-100ug | Biomatik Corporation | 100ug | EUR 517 |
Recombinant Glycoprotein 130 (gp130) |
|||
RPU41705-1mg | Biomatik Corporation | 1mg | EUR 2293.2 |
Recombinant Glycoprotein 130 (gp130) |
|||
RPU41705-50ug | Biomatik Corporation | 50ug | EUR 415.8 |
Recombinant Glycoprotein 130 (gp130) |
|||
RPU41706-100ug | Biomatik Corporation | 100ug | EUR 517 |
Recombinant Glycoprotein 130 (gp130) |
|||
RPU41706-1mg | Biomatik Corporation | 1mg | EUR 2293.2 |
Recombinant Glycoprotein 130 (gp130) |
|||
RPU41706-50ug | Biomatik Corporation | 50ug | EUR 415.8 |
Axy I unit: 130 |
|||
YRAXY1 | Yeastern Biotech | 1 vial | Ask for price |
LEP(116-130)(mouse) |
|||
TP1305-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: LEP(116-130)(mouse) |
LEP(116-130)(mouse) |
|||
TP1305-1g | TargetMol Chemicals | 1g | Ask for price |
Description: LEP(116-130)(mouse) |
LEP(116-130)(mouse) |
|||
TP1305-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: LEP(116-130)(mouse) |
LEP(116-130)(mouse) |
|||
TP1305-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: LEP(116-130)(mouse) |
LEP(116-130)(mouse) |
|||
TP1305-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: LEP(116-130)(mouse) |
Glycoprotein 130 (gp130) Antibody |
|||
abx101623-100l | Abbexa | 100 µl | EUR 212.5 |
Glycoprotein 130 (gp130) Antibody |
|||
abx101623-1ml | Abbexa | 1 ml | EUR 512.5 |
Glycoprotein 130 (gp130) Antibody |
|||
abx101623-200l | Abbexa | 200 µl | EUR 262.5 |
Glycoprotein 130 (gp130) Antibody |
|||
abx101624-100l | Abbexa | 100 µl | EUR 212.5 |
Glycoprotein 130 (gp130) Antibody |
|||
abx101624-1ml | Abbexa | 1 ml | EUR 512.5 |
Glycoprotein 130 (gp130) Antibody |
|||
abx101624-200l | Abbexa | 200 µl | EUR 262.5 |
Glycoprotein 130 (gp130) Antibody |
|||
abx129814-100l | Abbexa | 100 µl | EUR 262.5 |
Glycoprotein 130 (gp130) Antibody |
|||
abx129814-1ml | Abbexa | 1 ml | EUR 687.5 |
Glycoprotein 130 (gp130) Antibody |
|||
abx129814-200l | Abbexa | 200 µl | EUR 325 |
Glycoprotein 130 (gp130) Antibody |
|||
abx172638-1ml | Abbexa | 1 ml | EUR 625 |
Glycoprotein 130 (gp130) Antibody |
|||
abx172639-1ml | Abbexa | 1 ml | EUR 775 |
Secretogranin-1 (88-130) |
|||
066-62 | PHOENIX PEPTIDE | 100 μg | EUR 355.32 |
IL16 (130 a.a.) Protein |
|||
abx262202-10mg | Abbexa | 10 mg | EUR 325 |
IL16 (130 a.a.) Protein |
|||
abx262202-25mg | Abbexa | 25 mg | EUR 5975 |
IL16 (130 a.a.) Protein |
|||
abx262202-5mg | Abbexa | 5 mg | EUR 225 |
Leptin (116-130) Peptide |
|||
abx265393-100tests | Abbexa | 100 tests | EUR 487.5 |
Leptin (116-130) Peptide |
|||
abx265393-200tests | Abbexa | 200 tests | Ask for price |
Leptin (116-130) Peptide |
|||
abx265393-50tests | Abbexa | 50 tests | EUR 325 |
Glycoprotein 130 (gp130) Antibody |
|||
abx130860-100l | Abbexa | 100 µl | EUR 262.5 |
Glycoprotein 130 (gp130) Antibody |
|||
abx130860-500l | Abbexa | 500 µl | EUR 337.5 |
Musclin (80-130) / Osteocrin (Ostn) (80-130) (Mouse) - I-125 Labeled |
|||
T-028-69 | PHOENIX PEPTIDE | 10 μCi | EUR 1145.88 |
Rat Glycoprotein 130 (gp130) Protein |
|||
20-abx069730 | Abbexa |
|
|
Human Glycoprotein 130 (gp130) Protein |
|||
20-abx066881 | Abbexa |
|
|
Human Glycoprotein 130 (gp130) Protein |
|||
20-abx066882 | Abbexa |
|
|
HBcAg (a.a. 130-140) Antibody |
|||
abx021793-100ug | Abbexa | 100 ug | EUR 678 |
Anti-Human gp-130 Antibody |
|||
101-M441 | ReliaTech | 100 µg | EUR 399 |
Description: Gp130, the common signal transducing receptor component shared by the functional receptor complexes of the IL-6 family of cytokines, belongs to the classI cytokine receptor family. Binding of IL-6 or IL-11 to either the membrane-anchored or soluble IL-6 R or IL-11 R, respectively, initiates the association of IL-6 R (IL-11 R) with gp130. The complex then undergoes homodimerization and signal transduction. For other IL-6 family cytokines, such as LIF and OSM, signal transduction is similarly triggered by the heterodimerization of gp130 with LIFR or OSM R. |
Anti-Human gp-130 Antibody |
|||
101-M761 | ReliaTech | 100 µg | EUR 399 |
Description: Gp130, the common signal transducing receptor component shared by the functional receptor complexes of the IL-6 family of cytokines, belongs to the classI cytokine receptor family. Binding of IL-6 or IL-11 to either the membrane-anchored or soluble IL-6 R or IL-11 R, respectively, initiates the association of IL-6 R (IL-11 R) with gp130. The complex then undergoes homodimerization and signal transduction. For other IL-6 family cytokines, such as LIF and OSM, signal transduction is similarly triggered by the heterodimerization of gp130 with LIFR or OSM R. |
Anti-Mouse gp-130 Antibody |
|||
103-M483 | ReliaTech | 100 µg | EUR 399 |
Description: Gp130, the common signal transducing receptor component shared by the functional receptor complexes of the IL-6 family of cytokines, belongs to the classI cytokine receptor family. Binding of IL-6 or IL-11 to either the membrane-anchored or soluble IL-6 R or IL-11 R, respectively, initiates the association of IL-6 R (IL-11 R) with gp130. The complex then undergoes homodimerization and signal transduction. For other IL-6 family cytokines, such as LIF and OSM, signal transduction is similarly triggered by the heterodimerization of gp130 with LIFR or OSM R. |
Leptin (116-130) amide (mouse) |
|||
4100832.0001 | Bachem | 1 mg | EUR 168.53 |
Leptin (116-130) amide (mouse) |
|||
4100832.0005 | Bachem | 5 mg | EUR 675.26 |
Glycoprotein 130 (gp130) Antibody (Biotin) |
|||
20-abx271899 | Abbexa |
|
|
Mouse Glycoprotein 130 (gp130) Protein |
|||
20-abx167413 | Abbexa |
|
|
CMV Pp28 (aa 130 - 160) |
|||
DAG2392 | Creative Diagnostics | 100 µg | EUR 868.8 |
Human Beta-defensin 130 (DEFB130) |
|||
1-CSB-YP653750HU | Cusabio |
|
|
Description: Recombinant Human Beta-defensin 130(DEFB130) expressed in Yeast |
Porcine Glucoprotein 130 ELISA kit |
|||
E01A57121 | BlueGene | 96T | EUR 700 |
Description: ELISA |
Human Glucoprotein 130 ELISA kit |
|||
E01A4734 | BlueGene | 96T | EUR 700 |
Description: ELISA |